Aria CV
PrivateLast Round
Series C
Aug 18, 2025
Est. Valuation
$68.6M
Total Funding Raised
$57.32M
Company Overview
Aria CV operates in Healthcare & Life Sciences and is based in Saint Paul, Minnesota. Its latest recorded funding round was a Series C round in August 2025.
Aria CV is a medical device company that develops implantable systems for the treatment of pulmonary hypertension.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Aria CV Comparables
Compare Aria CV with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Pulnovo Medical | 78% | |
| Axon Therapies | 71% | |
| CorWave | 70% |
For institutional investors. Book with your work email.
Aria CV Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Aug 18, 2025 | ||||
| Debt | Jul 1, 2022 | ||||
| Accelerator | Jun 15, 2021 | ||||
| Series B | Feb 25, 2020 | ||||
| Series A Extension | Mar 12, 2018 | ||||
Series A | Jul 1, 2015 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Aria CV Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Cedar Point Capital, LLC | Series A |
| Xeraya Capital | Series B |
| CHV | Series B, Series A |
| KOFA Healthcare | Series C |
| Cedar Point Capital | Series B, Series A |
| BioStar Capital | Series C, Series B |
| Longview Partners | Series B |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 18, 2025
Raised $4M from KOFA Healthcare and BioStar Capital.
- Feb 25, 2020
$31M round led by Xeraya Capital.
For institutional investors. Book with your work email.
Aria CV Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Aria CV's valuation, stock price, and market status.
Is Aria CV a public or private company?
Aria CV is a private company.
What is the current stock price of Aria CV?
Aria CV is a private company, so its shares have no public market price. Caplight tracks Aria CV's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Aria CV worth (valuation)?
Aria CV's valuation is estimated at $68.6M based on funding round data.
Can I buy Aria CV stock?
Aria CV shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Aria CV's last funding round?
Aria CV's most recent funding round was Series C on August 18, 2025.
Who are the main investors in Aria CV?
Key investors in Aria CV include Xeraya Capital, CHV, Catalyst Health Ventures.
Will Aria CV IPO soon?
No public IPO plans have been announced for Aria CV.
How can I track Aria CV secondary market activity?
Caplight tracks bids, offers, and trades in Aria CV's shares on secondary markets.